Dr LO Su-vuiMB Bch (Wales), FHKCCM, FHKAM (Community Medicine), FFPHM, MRCP (UK), FRACMA
Dr Lo joined Hong Kong Genome Institute (HKGI) as the Chief Executive Officer in March 2021. As the CEO, Dr Lo leads HKGI in formulating its strategic direction and development plan. He also provides leadership to the team in launching the Hong Kong Genome Project, the city’s first-ever large-scale whole genome sequencing initiative. With the aspiration to benefit the wider community, Dr Lo drives the team to be the change agent in fostering clinical application of genomic medicine and its long-term development in Hong Kong.
Dr Lo is a seasoned professional in public health and administrative medicine, bringing with him a wealth of knowledge in public healthcare system, service provision and relevant policies. He also has a strong blend of experience in corporate affairs, strategic planning, talent development, research and so on. Prior to his current role, Dr Lo had served in the Hospital Authority (HA) for over 20 years during which he had held various senior management positions, including Director of Strategy & Planning in the HA Head Office and Cluster Chief Executive of the New Territories East Cluster.
In addition to his extensive experience with the HA, Dr Lo also held a number of senior positions both locally and overseas. These included being the Head of Research Office in the former Food and Health Bureau (currently the Health Bureau) of the HKSAR Government, and the Director of Purchasing (Specialist Care Services) with the Cardiff Health Authority of the National Health Service in the United Kingdom.
Professionally, Dr Lo is a practitioner in Public Health & Administrative Medicine. He had served as a Part I and II examiner of the Faculty of Public Health, and Censor and examiner of the Royal Australasian College of Medical Administrators.
Richard TSE Kin-pangFCPA, FCA (Aus), FCG, HKFCG
Mr Tse joined Hong Kong Genome Institute (HKGI) as the Chief Administrative Officer in October 2020. He oversees HKGI’s corporate services and external affairs, including finance, procurement, information technology, legal and human resources, as well as corporate communications and board secretariat. He is also responsible for leading on-going efforts to enhance the corporate governance and operational efficiency and to ensure the smooth implementation of the Hong Kong Genome Project, while raising the awareness of the general public on genomic medicine and the far-reaching benefits it brings along.
Mr Tse has 30 years of extensive experience in administrative and finance areas, covering a spectrum of strategic management roles in financial management, business development, operations management, corporate services and governance. Between 2014 and 2019, he was the Chief Financial Officer of the West Kowloon Cultural District Authority. Previously, he held various senior management positions in large established public bodies and multi-national corporations, including the Hong Kong Science and Technology Parks Corporation, Jardine Matheson Group and Ernst & Young’s Hong Kong and Sydney Offices.
Mr Tse has been involved in professional and community services, and he currently serves as a member of Branding and Communication Committee of the Hong Kong Institute of Certified Public Accountants (HKICPA). He was the Chairman of its Qualification and Examinations Board and a Council Member of the HKICPA from 2014 to 2016. In 1997, he was awarded as ‘Young Accountant of the Year’ by the HKICPA for his outstanding contribution to the accounting profession.
Mr Tse graduated with Bachelor of Commerce and Master of Commerce degrees from the University of New South Wales, Australia. He is a fellow member of the HKICPA, the Chartered Accountants Australia & New Zealand, and the Hong Kong Chartered Governance Institute.
Dr Brian CHUNG Hon-yinMBBS (Hons, HKU), MSc (Genomics and Bioinformatics, CUHK), MD (HKU), DCH (Ireland), MRCPCH (UK), FHKAM (Paediatrics), FRCPCH (UK), FCCMG (Clinical Genetics, Canada)
Dr Chung joined Hong Kong Genome Institute (HKGI) as the Chief Scientific Officer in February 2021, overseeing all scientific activities, including the clinical, ethics and research protocols of the Hong Kong Genome Project. He also supervises the operation of HKGI’s laboratory and works closely with Partnering Centres to mainstream genomic medicine.
Dr Chung was initially trained at The University of Hong Kong (HKU) (2000-2006) and subsequently at the University of Toronto, The Hospital for Sick Children (2007-2010), specialising in Paediatrics and Clinical Genetics. He obtained his fellowship of the Canadian College of Medical Geneticists, and later became a founding fellow of the subspecialty of Genetics & Genomics (Paediatrics) of Hong Kong Academy of Medicine (HKAM).
To further his career in genomics, he completed his Master of Science degree in Genomics and Bioinformatics at The Chinese University of Hong Kong in 2013 and obtained a Doctor of Medicine degree from HKU in 2018 with the Sir Patrick Manson Gold Medal.
For his achievements in research, he was honoured to have received the Best Young Investigator Prize of the Hong Kong College of Paediatricians in 2017. In recognition of his excellence in teaching, Dr Chung received a 2018 Faculty Teaching Medal and a 2019 Outstanding Teaching Award from HKU. He was also actively involved in the drafting of the postgraduate curriculum of the subspecialty of Genetics & Genomics (Paediatrics) of HKAM in 2017.
He is currently the President-Elect of the Asia Pacific Society of Human Genetics. His other responsibilities include having served on the Working Group of the Hong Kong Hospital Authority Strategic Service Framework for Genetic and Genomic Services.